MorphoSys Continues to Build Commercial Presence by Opening new U.S. Headoffice
PLANEGG/MUNICH, GERMANY and BOSTON MA / ACCESSWIRE / November 15, 2019 / MorphoSys (FSE: MOR; Prime…
Staff
CORRECTION: AIM ImmunoTech Provides Business Update for the Third Quarter of 2019
This press release replaces the press release issued 11/15/2019 at 6:30 a.m., which included an…
Humanigen to Present at the 2019 Stifel Healthcare Conference
BURLINGAME, CA / ACCESSWIRE / November 15, 2019 / Humanigen, Inc., (OTCQB:HGEN) (“Humanigen”), a clinical…
Applied BioSciences Reports Second Quarter Fiscal Year 2020 Financial Results and Outlines Corporate Strategy
Successfully building BioPharma pipeline in high-value indications Company plans to advance IND-cleared program into a…
Heat Biologics Reports Third Quarter 2019 Results and Provides Corporate Update
Reported Positive Phase 2 Interim Data in Advanced Non-Small Cell Lung Cancer Patients MORRISVILLE, NC…
StageZero Life Sciences Announces Q3 2019 Progress Update
TORONTO, ON / ACCESSWIRE / November 15, 2019 / StageZero Life Sciences, Ltd (TSX:SZLS) (”StageZero”…
AIM ImmunoTech Provides Business Update for the Third Quarter of 2019
OCALA, FL / ACCESSWIRE / November 15, 2019 / AIM ImmunoTech (NYSE American:AIM), an immuno-pharma…
Anika Therapeutics Announces Participation in MEDICA International Trade Fair and International Cartilage Regeneration and Joint Preservation Society Focus Meeting
BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies…
Sphingotec to Present Novel Acute Care Biomarkers and Point-of-Care Diagnostic Solutions at Medica 2019
HENNIGSDORF, GERMANY / ACCESSWIRE / November 15, 2019 / SphingoTec GmbH (“sphingotec”) today announced that…
Axonics® Announces Third Quarter 2019 Financial Results and Operational Update
IRVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed…